4//SEC Filing
KARBE FRANK 4
Accession 0000899243-22-031206
CIK 0001832415other
Filed
Sep 14, 8:00 PM ET
Accepted
Sep 15, 8:53 PM ET
Size
5.2 KB
Accession
0000899243-22-031206
Insider Transaction Report
Form 4
KARBE FRANK
DirectorSee Remarks
Transactions
- Purchase
Common Stock
2022-09-15$2.09/sh+50,000$104,695→ 50,000 total
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.06 to $2.10, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Documents
Issuer
Better Therapeutics, Inc.
CIK 0001832415
Entity typeother
Related Parties
1- filerCIK 0001276700
Filing Metadata
- Form type
- 4
- Filed
- Sep 14, 8:00 PM ET
- Accepted
- Sep 15, 8:53 PM ET
- Size
- 5.2 KB